0001225208-13-011703.txt : 20130508
0001225208-13-011703.hdr.sgml : 20130508
20130508174019
ACCESSION NUMBER: 0001225208-13-011703
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20130507
FILED AS OF DATE: 20130508
DATE AS OF CHANGE: 20130508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REINHARDT UWE E
CENTRAL INDEX KEY: 0001191250
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 13825810
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORP
STREET 2: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 508-650-8000
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
4
1
doc4.xml
X0306
4
2013-05-07
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001191250
REINHARDT UWE E
ONE BOSTON SCIENTIFIC PLACE
NATICK
MA
01760-1537
1
Common Stock
2013-05-07
4
A
0
22756.0000
0.0000
A
146202.0000
D
Common Stock
5000.0000
I
By Spouse
Annual grant of restricted stock vesting in full upon the expiration of non-employee director's current term of office. Reflects a value of $175,000 divided by the closing price of common stock on the date of grant.
reinhardtpoa.txt
/s/ Conor Kilroy, Attorney-in-Fact
2013-05-08
EX-99
2
reinhardtpoa.txt
POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes and appoints
each of Timothy A. Pratt,
Vance R. Brown, Theresa R. Boni, Todd D. Hammond and Conor Kilroy signing
singly, the undersigned's true
and lawful attorney-in-fact to:
(1) prepare and execute in the undersigned's name and on the undersigned's
behalf, and submit to
the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including
amendments thereto, and any other documents necessary or appropriate to obtain
codes and
passwords enabling the undersigned to make electronic filings with the SEC of
reports
required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or
any rule or
regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive
officer and/or director of Boston Scientific Corporation (the "Company"), Forms
3, 4 and 5, and
amendments thereto, in accordance with Section 16(a) of the Securities Exchange
Act of 1934, as
amended, and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or
desirable to complete and execute any such Form 3, 4 or 5 and file such form
with the SEC and
any stock exchange or similar authority;
(4) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive
officer and/or director of the Company, Forms 144 in accordance with Rule 144 of
the Securities
Act of 1933, as amended, and the rules and regulations thereunder; and
(5) take any other action of any type whatsoever in connection with the
foregoing which, in the
opinion of such attorney-in-fact, may be of benefit to, in the best interest of,
or legally required
by, the undersigned, it being understood that the documents executed by such
attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney shall be in such
form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's
discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform
any and every act and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if
personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is
the Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities
Exchange Act of 1934, as amended, or Rule 144 of the Securities Act of 1933, as
amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to
file Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings
of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this
20th day of January, 2013.
/s/ Uwe E. Reinhardt, Ph.D.
______________________
Uwe E. Reinhardt, Ph.D.